The Clinical Study Protocol & Informed Consent Architecture
The ethical and operational foundation governing all clinical trials, subject eligibility, and data collection.
📌 Direct Answer / Executive Definition
The Clinical Study Protocol is the comprehensive master plan approved by Institutional Review Boards (IRB/IEC) that defines the study objectives, inclusion/exclusion criteria, dosing regimens, visit schedules, and endpoint measurements. Informed Consent is the legally mandated process ensuring subjects voluntarily agree to participate after receiving transparent disclosure of trial risks and benefits.
Why Protocol Integrity & Informed Consent Mandates Matter in Clinical Trials
Every SAS dataset, SDTM domain, and protocol deviation check originates from the rules explicitly defined in the study protocol and consent documentation.
Standard Syntax, Derivation & Framework Pattern
/* Checking Subject Eligibility & Inclusion Criteria */
DATA work.eligibility_check;
SET raw.ie;
WHERE IECAT = 'INCLUSION';
IF IETESTCD = 'AGE' AND (IEORRES_NUM < 18 OR IEORRES_NUM > 75) THEN
Protocol_Violation = 'Y';
ELSE Protocol_Violation = 'N';
RUN;
Core Rules & Certification Takeaways
- The Clinical Study Protocol must be approved by an Institutional Review Board (IRB) or Ethics Committee before patient enrollment.
- Inclusion/Exclusion criteria define the exact patient population eligible for trial randomization.
- Informed consent must be obtained and signed *before* any study-related procedure or treatment is performed.
- Protocol amendments trigger updates to eCRF database specifications and downstream SDTM mapping rules.
🔗 Related Architectural Concepts & Next Steps
Deepen your mastery with connected topics across our curriculum and knowledge hubs.
Frequently Asked Questions (FAQ)
Who approves the Clinical Study Protocol before a trial starts?
The protocol must be reviewed and approved by the regulatory health authorities (such as the FDA/EMA) and an independent Institutional Review Board (IRB) or Ethics Committee.
Can a subject withdraw informed consent during a trial?
Yes. Informed consent is voluntary, and participants can withdraw from the clinical trial at any time without penalty or loss of medical care.
Want complete video breakdowns & exercises?
Explore full step-by-step masterclass training in Clinical SAS Programming & Clinical Trials.